Physica TT Tibial Plate Prospective Study
A Post Market, Prospective Clinical Study Evaluating Clinical and Radiographic Outcomes of Patients Undergoing Total Knee Arthroplasty with Physica TT Tibial Plate
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Domizia Baldassi
- Phone Number: +39 3357492586
- Email: domizia.baldassi@enovis.com
Study Contact Backup
- Name: Francesca Citossi
- Email: francesca.citossi@enovis.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient requiring a total knee arthroplasty (TKA) and suitable for receiving Physica TT Tibial Plate;
- Age ≥ 18 years old;
Candidate for primary total knee replacement when clinical indications based on physical examination and medical history include one or more of the following conditions:
- Non-inflammatory degenerative joint disease such as knee osteoarthritis, post traumatic knee arthritis;
- Inflammatory degenerative joint disease such as rheumatoid arthritis;
- Patient has well-preserved and well-functioning collateral ligaments
- Patient is able to understand the conditions of the study, is willing and able to follow all prescribed rehabilitation as well as willing to perform all scheduled follow-up visits;
- Patient has signed the study-specific Informed Consent Form prior to study activities
Exclusion Criteria:
Patient is affected by one or more of the conditions that are stated as Physica contraindications for use, which are:
- Severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function.
- Any active or suspected infection (local or systemic) or previous history of infection that may affect the prosthetic joint.
- Significant bone loss on femoral or tibial joint side.
- Known incompatibility or allergy to the product materials, and/or metal hypersensitivity to implant materials.
- Septicaemia.
- Persistent acute or chronic osteomyelitis.
- Open epiphyses (immature patient with active bone growth).
- Necrotic bone
- Arterial vascular insufficiency or nerve diseases of the lower limbs severe enough to interfere with the study evaluation.
- Compromised bone stock due to disease, infection or prior implantation that cannot provide adequate support and/or fixation to the prosthesis.
- Systemic or metabolic disorders leading to progressive bone deterioration, which may impair fixation and stability of the implant.
- Any concomitant disease and dependency that might affect the performance of the implanted prosthesis.
- Important osteoporosis, haemophilic disease.
- Internistic problems with high risk for surgery.
- Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy.
- Affected by malignant cancer with life expectancy less than 2 years or where cancer treatment might affect the normal postoperative course.
- Any clinically major pathology based on clinical medical history or any medical intervention or reason that the Investigator feels may affect the study evaluation.
- Neurological or musculoskeletal disorder or disease that may adversely affect gait, functional recovery and evaluation.
- Neuromuscular or neurosensory deficit that would hamper the performance assessment of the device.
- Any psychiatric illness that would prevent comprehension of the details and nature of the study.
- Simultaneously taking part in another surgical intervention study or pain management study that may affect with clinical study outcomes.
- Female patient who is pregnant, nursing, or planning a pregnancy.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Physica TT Tibial Plate
Total knee arthroplasty with Physica TT Tibial Plate
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Knee Society Score from preoperative to 2 years after surgery
Time Frame: From preoperative to 2 years after surgery
|
0-100 scale.
Scores rating from 80 to 100 are considered excellent, between 70 and 79 good, between 60 and 69 fair, and less than 60 poor
|
From preoperative to 2 years after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Oxford Knee Score
Time Frame: From preoperative to 2 years after surgery
|
Overall score from 0 to 48, with 48 being the best outcome
|
From preoperative to 2 years after surgery
|
|
Change in Range of Motion
Time Frame: From preoperative to 2 years after surgery
|
From preoperative to 2 years after surgery
|
|
|
Radiographic implant evaluation and stability assessment
Time Frame: From preoperative to 2 years after surgery
|
The treated knee is analyzed postoperatively based on knee x-rays.
The following parameters are evaluated: - Presence of radiolucent lines - Presence of osteolysis - Presence of loosening - Presence of heterotopic ossification - Presence of periprosthetic fractures
|
From preoperative to 2 years after surgery
|
|
Incidence, type and severity of Adverse Device Effects (ADE) and Serious Adverse Device Effects (SADE)
Time Frame: From preoperative to 2 years after surgery
|
From preoperative to 2 years after surgery
|
|
|
Implant survival rate
Time Frame: From preoperative to 2 years after surgery
|
From preoperative to 2 years after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- K-41
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
NCT07212647CompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)
-
NCT06717529CompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee Joint
-
NCT07551856Not yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the Knee
-
NCT07036003RecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)
-
NCT04814082RecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee Right
-
NCT07494838Not yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling Pain
-
NCT07624526Not yet recruitingKnee Osteoarthritis | Knee Arthritis
-
NCT07481474Not yet recruitingKnee Osteoarthritis (Knee OA)
-
NCT07443462Not yet recruitingKnee Osteoarthritis (Knee OA)
-
NCT07216586Not yet recruitingKnee Osteoarthritis | Arthritis Knee